Trial Profile
Phase IIa trial of dipraglurant in the treatment of focal cervical dystonia
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2016
Price :
$35
*
At a glance
- Drugs Dipraglurant (Primary)
- Indications Torticollis
- Focus Proof of concept; Therapeutic Use
- 17 Oct 2016 According to an Addex Therapeutics media release, anticipates the availability of data in the second half of 2017.
- 17 Oct 2016 According to an Addex Therapeutics media release, Buz Jinnah, Director of the Dystonia Coalition and Professor of Neurology at Emory University, will serve as the lead investigator.
- 17 Oct 2016 According to an Addex Therapeutics media release, this trial is expected to initiate in the fourth quarter of 2016.